Reports suggested that the molecular signaling pathways involved in regulating EMT and CSCs (NF-κB, MAPK, PI3K, mTOR, and JAK/STAT) upregulate PD-L1 in cancer cells [77,78]. Here, NFKB1 is linked to cancer.